Production of BP178, a derivative of the synthetic antibacterial peptide BP100, in the rice seed endosperm by Laura Montesinos et al.
RESEARCH ARTICLE Open Access
Production of BP178, a derivative of the
synthetic antibacterial peptide BP100, in
the rice seed endosperm
Laura Montesinos1, Mireia Bundó2, Esther Badosa1, Blanca San Segundo2, María Coca2 and Emilio Montesinos1*
Abstract
Background: BP178 peptide is a synthetic BP100-magainin derivative possessing strong inhibitory activity against
plant pathogenic bacteria, offering a great potential for future applications in plant protection and other fields. Here
we report the production and recovery of a bioactive BP178 peptide using rice seeds as biofactories.
Results: A synthetic gene encoding the BP178 peptide was prepared and introduced in rice plants. The gene was
efficiently expressed in transgenic rice under the control of an endosperm-specific promoter. Among the three
endosperm-specific rice promoters (Glutelin B1, Glutelin B4 or Globulin 1), best results were obtained when using the
Globulin 1 promoter. The BP178 peptide accumulated in the seed endosperm and was easily recovered from rice
seeds using a simple procedure with a yield of 21 μg/g. The transgene was stably inherited for at least three
generations, and peptide accumulation remained stable during long term storage of transgenic seeds. The purified
peptide showed in vitro activity against the bacterial plant pathogen Dickeya sp., the causal agent of the dark
brown sheath rot of rice. Seedlings of transgenic events showed enhanced resistance to the fungal pathogen
Fusarium verticillioides, supporting that the in planta produced peptide was biologically active.
Conclusions: The strategy developed in this work for the sustainable production of BP178 peptide using rice seeds
as biofactories represents a promising system for future production of peptides for plant protection and possibly in
other fields.
Keywords: Antimicrobial peptide, Oryza sativa, Rice biofactory, Protein bodies, Peptide recovery, Pathogen
resistance
Background
Antimicrobial peptides (AMPs) are components of the
innate immune system in animals and plants, and play
an important role in antagonistic relationships between
microorganisms [1–5]. There is a great expectation in
biotechnological applications of AMPs that include their
use as therapeutic agents, biopreservatives in cosmetics,
materials and food; and substitutes of antibiotics in
animal feed and in crop protection. AMPs are of
particular interest in the field of crop protection because
they meet the regulatory requirements for low environ-
mental impact of pesticides [3]. However, the exploit-
ation of natural AMPs presents limitations, as they are
produced in low amounts in the living organisms and
their extraction and purification requires complex and
costly procedures. In addition, natural AMPs might
show toxicity against non-target organisms [6].
The rational design of AMPs may overcome these lim-
itations by developing peptides with improved biological
properties, like increased antimicrobial activity and
stability, and reduced toxicity against non-targeted
organisms [7–9]. In this context, a library of synthetic
linear undecapeptides consisting of cecropin A (1–7)-
melittin (2–9) hybrids (named CECMEL11 library), was
previously obtained by combinatorial chemistry [8]. Sev-
eral peptides from this library showed potent antibacter-
ial and/or antifungal activities with low cytotoxicity
(hemolytic and phytotoxic activity) and moderate sus-
ceptibility to proteolytic degradation [6]. Among them,
the BP100 peptide exhibited strong activity against
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phytopathogenic bacteria and was effective in controlling
infections by different phytopathogens in apple, pear, to-
mato and pepper [7]. Another set of CECMEL11 pep-
tides (e.g. BP15, BP21) showed fungicidal activity and
were effective in the control of postharvest rot of fruits
[10] and brown spot of pear trees [11]. Some of the
CECMEL11 peptides (e.g. BP100, BP16) had cell pene-
trating properties in eukaryotic cells and have already
been used to deliver conjugated “cargo” compounds
intracellularly [12, 13]. Thus, CECMEL11 peptides rep-
resent useful tools in different fields of application. How-
ever, their exploitation requires the development of
sustainable and feasible means of production.
Production of AMPs in living systems used as biofac-
tories appears to be a promising alternative to the chem-
ical synthesis [14]. Several prokaryotic and eukaryotic
expression systems for the production of heterologous
proteins or peptides have been described using micro-
bial, insect or mammalian cells, and plants. All have ad-
vantages and disadvantages, depending on the type of
protein to be produced, the complexity of downstream
processes to recover it, and the cost. Microbial systems
based on bacteria and yeasts, provide high yield produc-
tion by fermentation processes and are easy to handle,
but the inclusion body formation requires solubilization
and refolding [15–17]. Procedures and the use of insect
and mammalian cells, or transgenic animals are complex
and expensive, with the additional disadvantages of the
slow-scaling up and the ethical concerns [18]. Trans-
genic plants offer several advantages for production of
AMPs in a cost effective manner, and therapeutic pro-
teins have already been produced [19–28]. In recent
years, commercial plant-derived proteins have been pro-
duced using cereal seeds [27, 29–32], and rice has been
chosen in several cases as a platform [23, 33, 34]. Differ-
ent rice promoters showing a seed-specific expression
pattern have been described [35, 36], and valuable re-
combinant proteins including vaccines, antibodies, cyto-
kines, hormones or enzymes have been successfully
produced in rice seeds [31, 37–42]. Most of these rice
based platforms produced peptides as multimers [43–45]
or as a fusion to a large protein carrier such as storage
proteins [46–50]. However, several reports show the diffi-
culty to produce small peptides in the rice seed due to its
small size, low stability and/or susceptibility to protease
degradation in planta [44, 47, 49, 51]. In order to achieve
the production of CECMEL11 peptides using plant biofac-
tories, synthetic analogs of the BP100 peptide that fulfill
specific requirements for optimal production in plants
were previously described [52]. Peptide modifications were
made to increase peptide size, and to incorporate reten-
tion signals targeting the peptide to specific cell compart-
ments (protein bodies, PB). A priori this strategy reduces
the risks of AMP degradation and/or toxicity towards
plant cells. The compounds (e.g. BP178) were evaluated
for antimicrobial, hemolytic and cytotoxic activities, and
several were considered as suitable candidates to be
produced in plant biofactories.
The aim of the present study was to determine the
feasibility of using the rice seed as a biofactory to
produce and recover a BP100 derivative, the BP178 anti-
bacterial peptide (29 amino acids, MW= 3.2 kDa). This
peptide has a lytic mode of action on several plant
pathogenic bacteria. Promoters of rice seed storage pro-
tein genes were used to direct endosperm-specific
expression of the AMP gene, and stable transgenic rice
plants accumulating the AMP in the seed endosperm
were generated. The peptide was easily purified from
rice seeds, and showed antimicrobial activity. Moreover,
transgenic seedlings showed resistance to pathogen in-
fection suggesting that the plant produced BP178 pep-
tide was also biologically active in the rice seed.
Results
Based on the library of BP134 derivatives [52], in which
modifications in peptide sequences were introduced to
facilitate their production in plant systems, we selected
the BP178 peptide for its production in rice seeds. This
peptide consisted of a magainin fragment linked to the
original sequence of the BP134 through an AGPA hinge
region, and the KDEL retention signal sequence
(KKLFKKILKYLAGPAGIGKFLHSAK-KDEL-OH) at the
C-terminus (Additional file 1). We reasoned that retention
into the endoplasmatic reticulum will protect the peptide
from proteolytic degradation while reducing the risk of
toxicity to the plant cell. The BP178 peptide exhibited
strong bactericidal effect against several plant pathogenic
bacteria with very low hemolytic activity. Phytotoxicity of
BP178 to tobacco cells was observed by infiltration only at
concentrations 50–100 times higher than minimal inhibi-
tory concentration MIC values [52]. The selected peptide
has a strong cationic net charge (pI = 10.84) with an
amphipathic character (Additional file 2).
Generation and characterization of transgenic rice plants
expressing a synthetic BP178 gene in seed tissues
Three different constructs were obtained in which the
synthetic BP178 gene was cloned under the control of
an endosperm-specific rice promoter (i.e. pGluB1:BP1
78:nos, pGluB4:BP178:nos and pGlb1:BP178:nos) (Fig. 1).
The promoters and the signal peptide coding sequence
of the rice glutelin B1, B4 and globulin genes were used
to direct the expression of the BP178 gene and accumu-
lation of the transgene product in the seed endosperm.
Transgenic T0 and homozygous plants were morpho-
logically similar to the wild-type untransformed plants.
All the regenerated rice lines recovered from different
transformation events had the complete cassette for
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BP178 expression integrated into their genomes, as re-
vealed by PCR analysis and subsequent sequencing of
the PCR products (Additional file 3). Most transgenic
lines carried a single copy insertion of both selectable
marker and the BP178 gene, that is 66.0% for the
pGlb1:BP178-lines, 100% for the pGluB4:BP178-lines
and 50% for the pGluB1:BP178-lines. As expected, a 3:1
segregation ratio was observed in T0 events harbouring
a single copy of the transgene. Single copy events were
used as the parental lines to obtain homozygous lines in
the T2 generation. Thus, independent homozygous lines
from pCGlb1:BP178:nos (5 lines), pCGluB4:BP178:nos (3
lines) and pCGluB1:BP178:nos (3 lines) transformation
events were selected for further analysis. Additionally,
qPCR analysis confirmed stable transgene inheritance
through successive generations (at least up to the T4
generation).
Production and accumulation of BP178 peptide in
transgenic rice seeds
The total protein profiles of transgenic and WT seeds were
initially examined by SDS-PAGE, and no significant differ-
ences were observed in the accumulation of native storage
proteins (e.g. glutelins, prolamins) when comparing trans-
genic and WT seed protein profiles (Fig. 2a and b).
The promoters and the signal peptide coding sequence
of the rice glutelin B1, B4 and globulin genes were used
to direct the expression of the BP178 gene and accumu-
lation of the transgene product. Previous studies demon-
strated the capability of these regulatory sequences to
produce the cecropin A peptide in the protein bodies of
the rice endosperm. Accordingly, in this work we pre-
pared protein body (PB)-enriched fractions from mature
seeds of transgenic lines harbouring a BP178 construct
following the procedure previously described [54]
(Additional file 4).
Western-blot analysis of PB proteins, using an anti-
BP178 polyclonal antibody, revealed accumulation of an
immunoreactive band, putatively BP178 peptide, in the
PB enriched fraction of the transgenic seeds harbouring
the pGlb1:BP178 construct, which was absent in the
same fraction of the empty vector seeds (Fig. 2c). Also, a
large variation in accumulation of BP178 was observed
among the different pGlb1:BP178 lines generated
(Additional file 5). We also noticed that the apparent
molecular weight of the BP178 peptide in Tricine-SDS
PAGE was larger (~8 kDa) than the expected molecular
Fig. 1 Schematic representation of the plant expression vectors for the expression of the BP178 gene in the rice endosperm. a Three different
constructs in pCAMBIA vector (pC) in which the synthetic gene was cloned between the endosperm-specific promoter including the signal peptide
coding sequence of the corresponding seed storage protein (SP) and the nopaline synthase terminator (nos). Relevant restriction enzyme sites for
cloning purposes are indicated. The hptII gene encoding resistance to hygromycin under the control of the CaMV35S promoter and terminator was
contained into the T-DNA region of pC. LB, left border; RB, right border of T-DNA. Arrows indicate the orientation of the sequence. b The chimeric
BP178 peptide corresponding to the fusion of BP134 (KKLFKKILKYL-OH, a cecropin A (1–7)-melittin (2–9) hybrid, in green) linked through the hinge
sequence (AGPA, in orange) to a magainin fragment peptide (GIGKFLHSAKKFGKAFVGEIMNS –OH, in blue); and extended with ER retention signal
(KDEL, in pink). For details, see Additional file 1: Figure S1
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weight for the corresponding peptide (3.2 kDa). In
addition, when high concentrations of the synthetic
BP178 peptide were subjected to immunoblot analysis,
at least three immunoreactive bands of different mobility
were detected (see Fig. 2), that could be associated to
peptide multimerization. No accumulation of the
BP178-immunoreactive band was observed in protein
extracts obtained from embryos, leaves or roots from
plants that expressed the BP178 gene under the control
of the seed-specific promoter (Fig. 2d).
LC-MS/MS proteomic analyses allowed the detection
of tryptic-derived peptides from BP178 that were un-
equivocally identified in the BP178-enriched protein
body fraction of pGlb1:BP178 lines, but not in the empty
vector controls. The expected tryptic fragments for the
peptide are indicated in Additional file 1 (highlighted se-
quences). LC-MS/MS data also confirmed that the
~8 kDa immunodetected polypeptide (Figs. 2c and 3;
Additional file 4) corresponded to the expected BP178
peptide in seeds of the pGlb1:BP178 lines, whereas the
tryptic peptides from the Glb1 signal peptide were not
detected in the PB samples. Analysis by LC-MS/MS also
demonstrated that BP178 accumulated in the protein
body enriched fraction obtained from pGluB1:BP178
and pGluB4:BP178 seeds, but at very low levels (~3
fmols/μL). Among the three strategies assessed for AMP
production, the pGlb1:BP178 seeds showed the highest
levels of BP178 accumulation. Among other factors, the
orientation of the expression cassettes could be associ-
ated with the increased expression of the BP178 gene in
the pGlb1:BP178 compared to that of pGluB1:BP178 or
pGluB4:BP178 seeds.
Further analysis confirmed that the BP178 peptide
remained stable during the germination process, as the
peptide was detected in the endosperm tissue of the ger-
minating seeds (3 and 7-day germinated seeds). No
BP178-related degradation products were observed in
protein extracts from germinating seeds (Fig. 3). More-
over, the in planta produced BP178 peptide was found
to accumulate in a stable manner during storage of the
Fig. 2 BP178 peptide accumulates in the endosperm of Glb1:BP178 transgenic rice seeds without altering accumulation levels of native storage
proteins. a Coomassie Blue staining of PB extracts from the indicated seeds. EV indicates seeds from plants transformed with the pCAMBIA 1300
empty vector. b Ponceau staining of protein samples (50 μg) c Western-blot analysis and quantification of the BP178 peptide in the protein
body-enriched fractions (50 μg) from mature seed endosperms of the indicated pGlb1:BP178, pGluB4:BP178, pGluB1:BP178 and empty vector (EV)
lines. The accumulation levels of BP178 peptide were quantified with the Quantity tools of the Chemidoc program using the 0.3, 0.15 and
0.05 μg amounts of synthetic BP178 peptide as a reference (taking into account the sum of the three bands observed). Numbers below the
western blot lanes correspond to μg of BP178 peptide. d Western-blot analysis of protein body-enriched fractions (50 μg) from embryos, leaves
or roots of the indicated pGlb1:BP178, and empty vector (EV) lines. For comparative purposes, 0.30, 0.15 and 0.05 μg of synthetic BP178 peptide
were run simultaneously in the Tricine-SDS gels. Immunodetection was performed using specific polyclonal anti-BP178KDEL antibodies and
coloured phosphatase alkaline reaction
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rice seeds as it could be detected in the transgenic seeds
even after long periods of storage (up to 3 years), when
stored at room temperature.
Preparative scale purification and yield estimation of the
BP178 peptide produced in seeds of transgenic rice
Knowing that the BP178 peptide accumulates in the rice
endosperm being detected in the PB enriched fraction,
we focused on the development of a method suitable for
purification of this peptide from transgenic rice seeds at
a preparative scale. The transgenic line 7, harbouring the
pGlb1:BP178 gene construct presented the highest level
of resistance to Dickeya sp. infection (see below). For
this, transgenic plants harbouring the pGlb1:BP178 (line
7) were selected. PB enriched fractions were obtained
from 1.500 seeds (30 g) of transgenic pGlb1:BP178
event. As control, PB fractions were obtained from
empty vector plants. The procedure used for purification
of BP178 from rice seeds is shown in Fig. 4a. In each
case, approximately 250 mg of PB proteins were
obtained. Next, protein extracts were obtained from PB
enriched fraction by precipitation using acetone-TCA-
DTT. Interestingly, under these conditions, the BP178
was found to be soluble, and the precipitated seed stor-
age proteins were easily removed from the protein body
extracts by centrifugation. BP178 peptide was recovered
from the acetone fraction, processed as described in the
experimental procedures, and further used. Western blot
analysis confirmed the presence of BP178 peptide in the
acetone fraction (Fig. 4b). This procedure was used to
recover the BP178 peptide accumulating in seeds of five
independent pGlb1:BP178 lines. The BP178 lines accu-
mulated the peptide in the range of 0.17 to 0.41 μg
/grain, as determined by western-blot analysis using
dilution series of BP178 (Fig. 4c). The highest contents
of BP178 was found in rice seeds of line 4.1, as 0.410 ±
0.037 μg/grain (21 μg/g of seed, 6.33 pmols/mg of seed).
The mean BP178 peptide yield for the 5 homozygous
BP178 lines was 0.299 ± 0.039 μg BP178/grain for the
3 year-old seeds, and 0.252 ± 0.085 μg BP178/grain in
the case of fresh seeds (0 year-old seeds). There were no
statistically significant differences between the BP178
Fig. 3 Stability of the BP178 peptide accumulated in 3 years-old seeds. The endosperm tissue was manually dissected from mature seeds (0-days)
and germinating rice seeds (3 and 7 days of germination). Protein extracts (35 μg) were separated by Tricine-SDS gels, transferred onto PVDF
membrane, and incubated with the anti-BP178 antibody followed by anti-rabbit IgG (Fc) alkaline phosphatase conjugated secondary antibody. EV,
rice plants with the empty pCAMBIA 1300 vector were used as a negative control, and 3.2 μg of synthetic BP178 were used as reference control.
Arrows, indicate BP178 A-related bands in rice extracts. Numbers in the left side indicate the size of the molecular markers (kDa). Lower panels
show Ponceau staining of protein samples
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accumulation levels among 0 year-old and 3 year-old seeds,
according to an ANOVA analysis (F = 0.251; P = 0.630).
BP178 peptide produced in rice seeds exhibits biological
activity
The antimicrobial activity of the in planta produced
BP178 peptide was assessed against the seedling bacter-
ial pathogen Dickeya sp. using a contact test. The bacter-
ial suspension was incubated with BP178 purified from
pGlb1:BP178 seeds or with purified fractions from empty
vector seeds. The BP178 contents of the two batches of
plant derived BP178 used were 0.41 and 0.46 μg/μl, re-
spectively. As expected, empty vector PB enriched frac-
tions had no BP178. Therefore, in the antimicrobial
activity assay, the corresponding total amounts were for
the synthetic BP178 of 0.05 μg, and for the purified
BP178 from transgenic seeds of 2.12 and 2.28 μg, for
each batch, respectively. The plant derived BP178
extracts and the reference synthetic BP178 peptide gave
similar bactericidal activities (Fig. 4d), but the concentra-
tions of the plant derived BP178 peptide were around
forty times higher.
Enhanced resistance of BP178-rice seeds to infection by
bacterial and fungal plant pathogens
Because the BP178 was found to accumulate in the rice
seeds, we investigated resistance to pathogen infection
in germinating seeds and seedlings. Dickeya sp. 1552-
10.1, a seedling bacterial pathogen, was used (Fig. 5). In
the presence of Dickeya sp., seedlings expressing
pGlb1:BP178 and pGluB4:BP178 were able to germinate
and presented normal root and shoot morphology com-
parable to that of control seedlings. These seedlings,
showed a consistent phenotype of resistance to infection
Fig. 4 Purification, quantification and antibacterial activity of the BP178 peptide recovered from the pGlb1:BP178 rice seeds. a Schematic
procedure for purification. BP178 peptide was recovered at high purity in the acetone supernatant (2) b Tris-Tricine SDS-PAGE and western-blot
analysis using anti-BP178 antibodies of fractions recovered during the purification process described in (a) starting from protein body fractions
(50 μg) from seeds from pGlb1:BP178 line 7.2. Numbers in the top of panel (b) correspond to: 1, Supernatant; 2, Pelleted protein bodies; 3, Pellet.
c Peptide yield from seeds of the indicated pGlb1:BP178 events. The amount of BP178 was calculated by comparing the signal intensity of known
amounts of standard (synthetic peptide). Values correspond to the mean of at least 3 independent assays and the standard error is indicated. d
Antimicrobial activity against Dickeya sp. of two batches of purified BP178-fractions from pGlb1:BP178 lines. Empty vector (EV) and reference
synthetic BP178 peptide were used as control. Mean values of two replicates and the standard error are indicated
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compared to control plants (WT, empty vector) that
showed susceptibility to Dickeya infection. Differences in
susceptibility occurred among lines harbouring the same
transgene. In contrast, the pGluB1: BP178 lines showed
susceptibility to Dickeya sp., at similar levels than con-
trol seeds. These plants exhibited short and brownish
shoots, and in most cases were unable to germinate in
the presence of the bacterial phytopathogen.
Resistance of BP178-rice seedlings against F. verticil-
lioides, a seed-borne fungal pathogen associated with
Bakanae in rice, was also assessed. It was observed a
better germination capability of the fungal-infected
transgenic seeds expressing the BP178 gene under the
control of an endosperm-specific promoter, compared to
control seeds (WT, empty vector) (Fig. 6). Most of WT
and EV seeds were unable to germinate in the presence
of the fungal pathogen and in some cases infected seed-
lings also show crown and stem rot, as well as low num-
ber of roots. More in detail, the expression of a BP178
gene under the control of the GluB1 and Glb1 promoter
resulted in higher level of protection to F. verticillioides
infection than GluB4:BP178-seeds.
Discussion
In this work, we generated transgenic rice plants accu-
mulating the BP178 peptide in the rice seed endosperm,
using endosperm-specific promoters to drive transgene
expression. The DNA sequence encoding the N-terminal
signal peptide of rice storage proteins was fused to the
BP178 gene, which also contained a C-terminal exten-
sion encoding the KDEL sequence for retention in the
ER. The homozygous rice seeds accumulating the BP178
peptide showed resistance to infection by two plant
pathogens, suggesting that the in planta-produced
peptide was biologically active. Moreover, the BP178
peptide was easily purified from the transgenic rice seeds
and was biologically active. There are several lines of evi-
dence to suggest that BP178 accumulates in PBs, while
subcellular location was not confirmed by direct methods
(e.g. immunolocalization). Such evidences include the
Fig. 5 Resistance of BP178 rice seeds to Dickeya sp. infection. a Phenotypical appearance of wild-type (Senia and Ariete cultivars), empty vector
(EV) and the transgenic seedlings carrying the indicated transgenes after 7 days in contact with Dickeya sp. 1552.10.1 bacterial suspensions
(107 cfu/mL). Pictures are representative of at least 2 independent assays in which 12 seeds per line were analysed. b Germination capability of
Dickeya-infected T3 rice seeds expressing the BP178 gene. Mean germination index (12 seeds) in inoculated (dark grey) or non-inoculated (pale
grey) seeds at 7 days after inoculation. Values correspond to the mean germination index of two independent assays. The standard error is also
indicated. The asterisks indicate statistically significant differences compared to the WT and empty vector mean (Tukey’s test, *p < 0.001)
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accumulation of a similar protein peptide (Cec A) to PBs
when identical regulatory sequences were utilized for
cloning and transformation, and also the presence of
BP178 in cell fractions that have been shown to be
enriched for protein bodies [53, 54].
It is worthwhile to mention that previous studies failed
to obtain stable transgenic rice plants expressing certain
BP100 derivative genes under the control of a constitu-
tive promoter, suggesting toxicity of these AMPs to the
host plant [55, 56]. In a few cases, the BP100 derivative
genes were constitutively expressed in rice, but resulted
in abnormal development of the plants [55]. On the
other hand, the suitability of endosperm-specific pro-
moters to drive expression of the cecropin A gene in the
rice endosperm has been demonstrated [54]. Altogether,
these findings highlight the relevance of using the appro-
priate strategy for production of AMPs in transgenic rice
to avoid undesirable effects, particularly for production
of the BP178 antibacterial peptide in rice seed tissues.
The BP178 peptide accumulated in the endosperm
tissue of the transgenic seeds, but not in embryo, leaf or
root tissues, which is in agreement with the already de-
scribed seed-specific activity of the GluB1, GluB4 and
Glb1 promoters [35]. It is known that both glutelin and
globulin rice seed storage proteins are synthesized in the
endoplasmic reticulum and deposited in the PBII (also
called protein storage vacuoles, [57]) of rice endosperm,
due to cis-acting RNA localization signals present in the
transcripts [58]. However, the sorting signals for seed
storage proteins deposition into PBII have not yet been
identified in rice [59]. Our results illustrate the utility of
using an endosperm-specific promoter and signal pep-
tide sequence of seed storage proteins for production of
BP178 in protein body enriched fractions of transgenic
rice seed. In this context, there are examples with other
peptides in which a similar strategy has been successful
[54] as well as unsuccessful [60]. Therefore, it should be
considered the possibility that the BP178 peptide accu-
mulates without the targeting signal sequence in the sig-
nal peptide. For instance, the BP178 peptide might
interact with seed storage proteins, as has been previ-
ously described for other peptides [40, 61]. Even, protein
aggregation may also play a role in protein sorting, as it
Fig. 6 Resistance of BP178-rice seeds to Fusarium verticillioides
infection. a Phenotypical appearance of wild-type (WT) and
transgenic seedlings carrying the indicated transgenes or the empty
vector (EV) 7 days after germination in contact with F. verticillioides
spore suspensions (105 spores/mL). Pictures are representative of 3
independent assays b Germination capability of the fungal inoculated
transgenic seeds referred to wild-type seeds. Values correspond to the
mean germination rate and standard errors of three independent
assays in which at least 3 independent lines per transgene were
analysed. Asterisks denote statistically significant differences with
wild-type and empty vector plants (Tukey’s test, *p < 0.001)
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has been reported for human lysozyme that contains an
internal targeting signal which directs the recombinant
protein to the PBs [62]. Clearly, further studies are re-
quired to confirm targeting of the BP178 peptide to PBs
and to identify the molecular determinants involved.
Fractionation procedures, in combination with
western-blot and LC-MS/MS analyses allowed us to
demonstrate that the BP178 peptide was efficiently
produced and accumulated in the endosperm in BP178-
transgenic events. In addition, this production was
without apparent interference on the accumulation of
the seed storage proteins such as glutelins and prola-
mins. In contrast, other studies reported adverse effects
of peptide accumulation in rice seeds. For instance, the
production of transgenic rice seeds accumulating the
major Japanese cedar pollen allergens, Cry j 1 and Cry j 2
at high levels, was accompanied by an important reduc-
tion in the accumulation of endogenous seed storage pro-
teins [63]. Similarly, a high level of accumulation in the
transgenic seeds of a hybrid peptide comprising seven pre-
dominant human T cell epitopes resulted in alterations in
the accumulation of seed storage proteins [64]. Presum-
ably, the accumulation of the BP178 peptide in the endo-
sperm of the rice seed prevents the ER stress response as
previously described by other authors [65]. Alternatively,
the accumulation of the BP178 might not have reached
the threshold level required to induce ER stress.
The in planta produced BP178 peptide exhibited an ap-
parent molecular weight in Tris-Tricine SDS-PAGE (mo-
bility) higher than expected (~8 kDa compared to 3.2 kDa
for this synthetic peptide). A similar phenomenon has
been reported in transgenic plants expressing other AMPs
[54, 55, 60, 66]. Different possibilities can explain the ab-
normal electrophoretic mobility of the plant produced
BP178 peptide, such as the formation of self-assembled
peptide multimers, an additional amino acidic fragment
between the C-terminal of the signal peptide sequence
(SGA—) and the N-terminal sequence of the BP178 pep-
tide (—KKL), post-translational modifications or an im-
proper processing of the signal peptide. However, the
tryptic peptide corresponding to the signal peptide was
not detected by LC-MS/MS analysis of the seed produced
BP178 peptide. It is also known that proteins that enter
into the secretory pathway are often modified in plant
cells by the addition of sugar chains. Probably, the strong
basic and amphipathic character of the BP178 and/or
multimerization might be responsible of its abnormal
electrophoretic mobility in SDS-PAGE gels.
A successful use of rice seeds as biofactories of AMPs
requires the stable expression of the transgene through
successive generations of plants, as well as stability of
the peptide during seed storage. BP178 accumulation
remained stable during storage of the rice seeds, at least
for three years, without significant loss of antimicrobial
activity. This stability can be associated to the adequate
biochemical environment of the PBs, which might pro-
tect the peptide from the action of endogenous proteases
[27, 29, 31, 54]. Furthermore, the amino acid compos-
ition and structure of the BP178 peptide can be also
responsible for the integrity of the peptide under these
conditions as has been argued for other peptides [53].
In the present work, a simplified method to recover
BP178 peptide from seeds was developed. The procedure
consists of a two-step centrifugation to partially-purify
protein bodies, from which the peptide was solubilized
in an acetone mix, whereas the seed storage proteins
were precipitated and removed. The plant derived
BP178 peptide showed bactericidal activity. Although
the activity was similar to the synthetic BP178 pep-
tide, the concentrations were around forty times
higher. It is possible there was a loss of activity of
the plant derived BP178 peptide related to its
abnormal electrophoretic mobility.
In the literature there are many examples of AMP genes
that have been successfully expressed in rice to obtain dis-
ease resistant transgenic plants [56, 66–71]. However, less
attention has been paid to develop plant biofactories for
the production of AMPs and to recover the expected
product. The processes for extraction and purification of
peptides in general and of cationic amphipathic AMPs in
particular, are often laborious and costly, often requiring
several steps [42, 72], and frequently complicated by the
interaction of the expression product with tissue compo-
nents or with the equipment used [40, 54, 73].
Current literature on production of peptides in rice seeds
shows both successful and unsuccessful experiences, but in
most cases repeated tandems or fusion proteins were used
[52, 74–76]. The system here developed for production of
BP178 was efficient without the need of using repeated tan-
dems or fusion of the AMP to a larger protein carrier.
Among the three strategies assayed in this work (e.g.
promoter used to drive transgen expression), seeds from
pGlb1:BP178 rice plants showed the highest accumula-
tion levels of BP178 in the seed endosperm (up to
21 μg/g of seed, as revealed by western blot analysis and
densitometric quantification). However, this value may
represent an underestimation of the actual concentra-
tions, because immunoblot detection of short and basic
AMPs might underestimate the peptide yield [55, 66,
77]. In addition, the yield of BP178 (6.33 pmols/mg of
seed) was in the upper range of the above mentioned
reports (0.03 to 10 pmols/mg of seed) and four times
higher than for cecropin A using a similar strategy (1.5
pmols/mg of seed) [54]. The observation that the in
planta produced BP178 peptide was biologically active
and effectively protects germinating seeds against phyto-
pathogens is in agreement with the accumulation of ef-
fective levels to confer antimicrobial activity [52]. This data
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additionally shows that the production of BP178 appears as
a useful approach for engineering broad-spectrum protec-
tion against seed-borne pathogens in rice grains.
In summary, the strategy presented here for expression
of peptide BP178 solves the limitation that was encoun-
tered with genes encoding highly cationic α-helical small
peptides showing toxicity towards the host plant [55, 56].
Overall, these results suggest that the endosperm tissue of
the rice seed can be considered as an appropriated plat-
form for the accumulation of BP178, with no need of
complex downstream processing steps for the elimination
of endogenous storage proteins. The method requires
minimum purification and processing steps, due to the
solubility in acetone of the transgene product, with a yield
suitable for their purification and further use of BP178 as
an antimicrobial agent. The system also allows for long-
term storage of the AMP-accumulating rice seeds and
does not affect the normal growth and development of the
plant. Thus, the rice-based BP178 peptide plant biofactory
offers new possibilities for the sustainable production of
this peptide and application, not only in crop protection,
but also in other fields (pharmaceuticals, preservatives).
Conclusions
The strategy presented here for expression of peptide
BP178 solve the limitation that was encountered with
genes encoding highly cationic α-helical small peptides
showing toxicity towards the host plant. Overall, these re-
sults suggest that the endosperm tissue of the rice seed
can be considered as an appropriated platform for the ac-
cumulation of BP178, with no need of complex down-
stream processing steps for the elimination of endogenous
storage proteins. The method requires minimum purifica-
tion and processing steps, due to the solubility in acetone
of the transgene product, with a yield suitable for their
purification and further use of BP178 as an antimicrobial
agent. The system also allows for long-term storage of the
AMP-accumulating rice seeds and does not affect the
normal growth and development of the plant. Thus, the
rice-based BP178 peptide plant biofactory offers new pos-
sibilities for the sustainable production of this peptide and
application, not only in crop protection, but also in other
fields (pharmaceuticals, preservatives).
Methods
Construction of vectors for rice transformation
Synthetic BP178 gene was designed based on the codon
usage bias in Oryza sativa, chemically synthetized and
cloned into the pUC57 plasmid (GenScript).
Three constructs for the expression of the BP178 gene
in rice plants were prepared (Fig. 1).
To drive expression of the BP178 gene, three rice seed
endosperm-specific promoters were chosen: glutelin B-1
(GluB1), glutelin B-4 (GluB4) and 26 kDa α-globulin (Glb1)
[35]. Additionally, the signal peptide sequence of the corre-
sponding rice endosperm storage protein (GluB1, GluB4 or
26 kDa Glb1) was fused to the N-terminus of the BP178
peptide sequence to direct its internalization into the ER
system of the plant cell, and presented in Additional file 1:
Figure S1. The sequence encoding the KDEL tetrapeptide
(ER-retention signal) was added in C-terminal.
The various endosperm-specific promoters containing
the 5′ untranslated region were isolated from genomic
DNA obtained from rice leaves (Oryza sativa ssp. japon-
ica cv. Senia, acquired from the rice source of the
Centre for Research in Agricultural Genomics, Barce-
lona, Spain). Oligonucleotide primers designed accord-
ing to the nucleotide sequences available at the EMBL/
GenBank/DDBJ nucleotide sequence database with ac-
cession numbers AY427569 (GluB1), AY427571 (GluB4)
and AY427575 (Glb1) [35] for the Nipponbare japonica
rice cultivar are shown in Additional file 5. The tissue-
specificity and activity of the three rice seed promoters
used in this work was previously described [35]. The
26 kDa globulin promoter was found to be active in the
inner starchy endosperm tissue, whilst the glutelin pro-
moters exhibited the highest promoter activity in the
outer portion of the endosperm.
The nucleotide sequence for the nopaline synthase ter-
minator (nos) from Agrobacterium tumefaciens was also
obtained by PCR using the plasmid pC::pUbi:Cec-
AKDEL:nos as the template [66]. All the PCR products
were gel-purified using a DNA purification column and
cloned into the pGEM ®T-Easy plasmid. Briefly, the
pGEM::nos and pGEM:endosperm promoter-signal pep-
tide (SP) vectors were digested with the appropriate re-
striction enzymes. The Nos terminator sequence was
cloned downstream of the promoter-SP, resulting in plas-
mids pGEM:endosperm promoter-SP:nos. Subsequently,
the synthetic BP178 gene was cloned into the pGEM::en-
dosperm promoter-SP:nos plasmid DNA using the indi-
cated restriction enzymes (Fig. 1). Previously, restriction
sites were introduced by PCR using the primers
described in Additional file 6. After verification by
sequencing, the complete cassette (endosperm promoter-
SP:BP178:nos) was cloned into the pCAMBIA1300 plant
expression vector, which already contains the hptII
(hygromycin phosphotransferase) gene encoding hygro-
mycin resistance in the T-DNA region.
The resulting binary vectors were transferred to
Agrobacterium tumefaciens EHA105 (obtained from the
Centre for Research in Agricultural Genomics, Barce-
lona, Spain) [78] for the stable rice transformation.
Production and characterization of transgenic rice plants
expressing the BP178 gene in seed tissues
Transgenic rice plants were produced by Agrobacterium-
mediated transformation [79] using the commercial
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cultivars Senia and Ariete (obtained from the rice source
of the Centre for Research in Agricultural Genomics,
Barcelona, Spain). Transformation with the pCAM-
BIA1300 empty vector was done in parallel as a control.
Transgene integration into the rice genome, and integrity
was examined by PCR analysis using genomic DNA ob-
tained from young leaves (T0 plants) [80]. PCR primers
were designed to amplify either the BP178 gene or the
complete cassette for expression of the AMP gene (that is
the promoter:BP178:nos DNA fragment). The transgene
copy number was estimated in all T0 regenerated
plants (and T3 plants) by quantitative PCR (qPCR)
targeting to either the AMP or the hptII genes
(primers, Additional file 7). The single copy gene,
β-actin, was used for normalization as previously
described [54, 56, 81].
To obtain homozygous lines and to analyse the hptII
inheritance, 24 randomly chosen T1 seeds of the se-
lected T0 transgenic lines were germinated in the pres-
ence of hygromycin. The offspring homozygous for hptII
gene was identified in the T2 lines, and T3 lines were
obtained by self-pollination of T2 plants. The primary
transgenic and next seed progenies were soil-grown to
maturity in the greenhouse at 28 °C/20 °C (day/night)
using a 12 h/12 h (day/night) photoperiod.
Purification and detection of the BP178 peptide from
protein bodies of rice seeds
A simplified method for preparation of partially purified
protein bodies was previously reported [54] and used in
the present work. Briefly, 1500 (30 g of seed) dehulled
mature seeds were soaked in water for 2 h and were ho-
mogenized at 4 °C in 100 mL of grinding buffer (0.6 M
Sucrose, 10 mM Na2HPO4, pH 7.5) and 7 mL of
enriched protein body fraction were obtained. Protein
extracts (50 μg) from PB enriched fractions were ana-
lysed on a Tris-Tricine SDS-PAGE gel, blotted onto
0.2 μm PVDF membrane and probed with the antibody
raised against the BP178 peptide (1:2000, GenScript).
Binding was detected using an Anti-Rabbit IgG (Fc)
Alkaline Phosphatase conjugate secondary antibody
(1:7500, Promega). The Western Blue®Stabilized sub-
strate served for visualization of alkaline phosphatase
activity (Promega). The signal of the BP178 peptide ac-
cumulated in the PB of transgenic lines was quantified
using the Quantity Tools Image Lab™ Software (Version
4.1) included in the ChemiDoc™ XRS+ System (Bio-Rad,
USA), by comparing the band intensity of the BP178
produced in seeds to that of reference amounts of syn-
thetic BP178 peptide at known concentrations, run in
the same gel. Since synthetic peptide shows generally n-
mer bands in western-blot analysis, the amount of the
standard peptide was calculated taking into account the
sum of all individual immunodetected bands. BP178
peptide was synthesized by the LIPPSO Laboratory
(Innovation Laboratory in Organic Chemistry Processes
and Products, University of Girona, Spain).
Crude protein from protein body enriched fraction
was obtained by adding ice cold-acetone (acetone-TCA-
DTT) containing 15% (v/v) TCA and 20 mM DTT to
the pelleted protein bodies, incubation for 60 min at
−20 °C and centrifugation at 13,000 × rpm for 23 min at
4 °C. After centrifugation, the supernatant was recovered
and evaporated to finally obtain a solid fraction enriched
with BP178 peptide free of starch, cell debris and most
of native seed storage proteins. Both, the supernatant
and pellet were analysed.
The identification of the BP178 peptide in PB enriched
fractions from transgenic rice seeds was performed using
an Agilent 1200 Nanoflow HPLC coupled to a 4000
QTRAP LC-MS/MS hybrid triple quadruple/linear ion
trap mass spectrometer using a microSpray source (AB/
MDS Sciex) as described previously [54].
For the BP178 peptide, four transitions were selected,
according to their relative intensity and m/z greater than
the precursor m/z (Additional file 8).
Antibacterial activity of the in planta produced BP178
The antibacterial activity of BP178 peptide produced in
rice seeds was assessed in vitro against Dickeya sp. 1552
10.1 (provided by Maria López, Reference Laboratory in
Plant Pathogenic Bacteria, Instituto Valenciano de Inves-
tigaciones Agrarias, Valencia, Spain) and compared to
that of synthetic BP178. Two batches of 25 mg of the
enriched protein body fraction (Additional file 5), were
used to obtain a partially purified plant derived BP178,
according to the procedure indicated in Fig. 4a, and then
the acetone supernatant was evaporated. The dried
supernatant from the acetone-TCA-DTT treated protein
bodies was used. Because TCA inhibited bacterial
growth, it was removed from the dried extract using
three consecutive washing cycles with 10 mM acetic acid
and evaporation. Finally, the dried BP178 acetate was
solubilized in diethyl ether, evaporated, and resuspended
in 20 μL water for the antibacterial assay. Western ana-
lysis was used to determine the BP178 contents were in
each batch. Empty vector PB enriched extracts were
treated similarly than BP178-seeds and included as con-
trol. Also synthetic BP178 (3.2 μM) followed the same
steps of the above mentioned protocol used to obtain
BP178 from seeds. For the assay, 10 μL of the bacterial
cells suspension (2 × 104 cfu/mL) were mixed with 10 μL
of the 3.2 μM synthetic BP178 or of the purified BP178
from transgenic seeds, and incubated for 2 h at 28 °C.
All samples were prepared in duplicate. After incuba-
tion, aliquots of 10 μL were plated onto LB agar and
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grown for 24 h at 28 °C, and viable cells determined.
The experiment was repeated twice.
Resistance of BP178 rice seedlings to pathogen infection
A seed germination test was used to determine the re-
sistance of BP178-seedlings to two plant pathogens, the
bacterial pathogen Dickeya sp. and the seed-borne
fungal pathogen Fusarium verticillioides (supplied by the
Plant Health Services, Generalitat de Catalunya, Barce-
lona, Spain). For the bacterial pathogen the assay was
performed as previously described with minor modifica-
tions [56]. Twelve surface-sterilized seeds were placed in
24-well culture chambers and inoculated with 500 μL of
water or a bacterial suspension (107 cfu/mL) and vac-
uum infiltrated. For the fungal pathogen the procedure
was as previously reported [54]. Seeds were inoculated
with 50 μl of a spore suspension at a concentration of
103 (cv. Senia) or 105 (cv. Ariete) spores/ml (water as
germination control) on MS medium without sucrose.
In both cases seeds were allowed to germinate at 28 °C
for seven days, using a 12 h/12 h (day/night) photo-
period under a photon flux of 110–150 μmol. m−2. s−1.
Then, disease intensity was estimated using a semi-quanti-
tative scale (0, not germinated seed; 0.5, germinated seed
with the seedling length less than 25% of control; 1.0,
germinated seed with the seedling length from 25 to less
than 50% of control; 1.5, germinated seed with the seed-
ling length from 50 to less than 75% of control; and 2.0,
germinated seed with the seedling of the same length as
the control seeds). Transgenic seeds were compared to
WT and empty vector seeds, and to non-pathogen inoc-
ulated seeds.
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